Global Hotels: Deceleration in Sight
Bright spots remain in hotel REITs
Chief Investment Office27 Mar 2025
  • 4Q24 results for Marriott and Hilton ended on a high note; inflation to drive organic RevPAR down
  • Trump policies may seem like an indirect blow to industry but may bite in more ways than one
  • US hotel revenues and booking demand has a sharp historical correlation to US GDP
  • Downshift in sentiment as Fed revises GDP forecasts for 2025 – 2027
  • Favour S-REITs with stable master lease income, lower operational risk & lower exposure to US hotels
Article image
Photo credit: Unsplash
Read More

Net room expansion to drive growth. Marriott and Hilton reported solid results to end FY24 supported by net unit growth. As RevPAR growth for FY25 is expected to ease and align with inflation of around 3%, US hoteliers are now shifting their focus towards expanding net room capacity to drive growth. Marriott projects net unit growth of approximately 4.5% next year, bolstered by diversification into non-traditional lodging segments, such as outdoor hospitality. Hilton, meanwhile, forecasts a more ambitious 6-7% net unit increase, driven by momentum from a record pipeline of upcoming rooms. These trends signal a normalisation of pent-up pandemic-era travel demand, with US hoteliers increasingly relying on expanding room inventory as a key growth lever heading into 2025.

Trump tariffs take toll on travel demand, margins, and developments. Trump administration policies with higher trade tariffs and anti-immigration policies may have a more direct impact on US hotel operations than expected. We foresee potential pressure on operating margins due to tariff-driven cost inflation affecting soft goods (eg: textiles) and FF&E (furniture, fixtures, and equipment). Higher construction and raw material costs from tariffs such as steel could mean costlier and lengthier renovation and constructions for US hoteliers. On the demand side, we see anti-immigration policies and tariffs on neighbouring countries (Mexico and Canada) amid heightening geopolitical friction that could discourage tourism and cross-border travels in both directions. Last but not least, the recent softening of US GDP growth forecast by the Federal Reserve for 2025 – 2027 could paint a more cautious picture for both leisure and corporate travel and hotel demand. 

Hotel REITs favoured over operators on business stability. Among regional hotel plays, we favour Singapore hotel S-REITs over US REITs. US hotel operators that may see pressure on operating margins and net unit growth targets as US construction sector feels the heat. S-REITs with stable hotel master leases while having limited exposure to US hotels are preferred. Meanwhile, we remain neutral on US hoteliers with share prices at a five-year historical high EV/EBITDA while leaving room for downside surprises.


Figure 1: Room pipeline as % of existing room count

Source: Companies, DBS



Download the PDF to read the full report.

Topic

Note: All views expressed are current as at the stated date of publication

DISCLAIMERS AND IMPORTANT NOTES

This information herein is published by DBS Bank Ltd. (“DBS Bank”) and is for information only. This publication is intended for DBS Bank and its subsidiaries or affiliates (collectively “DBS”) and clients to whom it has been delivered and may not be reproduced, transmitted or communicated to any other person without the prior written permission of DBS Bank. 

This publication is not and does not constitute or form part of any offer, recommendation, invitation or solicitation to you to subscribe to or to enter into any transaction as described, nor is it calculated to invite or permit the making of offers to the public to subscribe to or enter into any transaction for cash or other consideration and should not be viewed as such.

The information herein may be incomplete or condensed and it may not include a number of terms and provisions nor does it identify or define all or any of the risks associated to any actual transaction. Any terms, conditions and opinions contained herein may have been obtained from various sources and neither DBS nor any of their respective directors or employees (collectively the “DBS Group”) make any warranty, expressed or implied, as to its accuracy or completeness and thus assume no responsibility of it. The information herein may be subject to further revision, verification and updating and DBS Group undertakes no responsibility thereof.

All figures and amounts stated are for illustration purposes only and shall not bind DBS Group. DBS Group does not act as an adviser and assumes no fiduciary responsibility or liability for any consequences, financial or otherwise, arising from any arrangement or entrance into any transaction in reliance on the information contained herein.   The information herein does not have regard to the investment objectives, financial situation and particular needs of any specific person. In order to build your own independent analysis of any transaction and its consequences, you should consult your own independent financial, accounting, tax, legal or other competent professional advisors as you deem appropriate to ensure that any assessment you make is suitable for you in light of your own financial, accounting, tax, and legal constraints and objectives without relying in any way on DBS Group or any position which DBS Group might have expressed in this document or orally to you in the discussion.

Companies within the DBS Group or the directors or employees of the DBS Group or persons/entities connected to them may have positions in and may affect transactions in the underlying product(s) mentioned. Companies within the DBS Group may have alliances or other contractual agreements with the provider(s) of the underlying product(s) to market or sell its product(s). Where companies within the DBS Group are the product provider, such company may be receiving fees from the investors. In addition, companies within the DBS Group may also perform or seek to perform broking, investment banking and other banking or financial services to the companies or affiliates mentioned herein.

This publication may include quotation, comments or analysis. Any such quotation, comments or analysis have been prepared on assumptions and parameters that reflect our good faith, judgement or selection and therefore no warranty is given as to its accuracy, completeness or reasonableness. All information, estimates, forecasts and opinions included in this document or orally to you in the discussion constitute our judgement as of the date indicated and may be subject to change without notice. Changes in market conditions or in any assumptions may have material impact on any estimates or opinion stated.

Prices and availability of financial instruments are subject to change without notice. Any information relating to past performance, or any future forecast based on past performance or other assumptions, is not necessarily a reliable indicator of future results. Future results may not meet our/ your expectations due to a variety of economic, market and other factors.

This publication has not been reviewed or authorised by any regulatory authority in Singapore, Hong Kong, Dubai International Financial Centre, United Kingdom or elsewhere. There is no planned schedule or frequency for updating research publication relating to any issuer.

If this publication has been distributed by electronic transmission, such as e-mail, then such transmission cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrive late or incomplete, or contain viruses. The sender therefore does not accept liability for any errors or omissions in the contents of the Information, which may arise as a result of electronic transmission. If verification is required, please request for a hard-copy version.

The investment product(s) mentioned herein is/are not the only product(s) that is/are aligned with the views stated in the research report(s) and may not be the most preferred or suitable product for you. There are other investment product(s) available in the market which may better suit your investment profile, objectives and financial situation.

This publication is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation.

Country Specific Disclaimer

This publication is distributed by DBS Bank Ltd (Company Regn. No. 196800306E) ("DBS") which is an Exempt Financial Adviser as defined in the Financial Advisers Act and regulated by the Monetary Authority of Singapore (the "MAS").

This publication is provided to you as an “Accredited Investor” (defined under the Securities and Futures Act of Singapore and the Securities and Futures (Classes of Investors) Regulations 2018) or an “Institutional Investor” (defined under the Securities and Futures Act of Singapore and the Securities and Futures (Classes of Investors) Regulations 2018) for your private use only and may not be passed on or disclosed to any person nor copied or reproduced in any manner.